Polycystic ovarian syndrome (PCOS) is caused by abnormal production of androgens
resulting in the formation of small fluid‐filled sacs in the ovaries. This condition worsens the …

Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in
reproductive age women and is associated with both reproductive and metabolic …

Background and Objectives: In women of reproductive age, leukocytosis is a risk factor that
bridges low-grade chronic inflammation (metabolic inflammation), metabolic changes, and …

Objective Polycystic ovarian syndrome is a complex reproductive as well as
endocrinological disorder characterized by anovulatory dysfunction, androgen excess and …

Polycystic ovarian syndrome (PCOS) is a disease impacting adult female in which its main
features are hyperandrogenism, insulin resistance‎‎(IR), hyperinsulinemia, which enhances …

Background: Polycystic ovary syndrome (PCOS) is the most frequent endocrine disorder
seen in pre-menopausal women, affecting 5-10% of this population. It is characterized by …

Background Polycystic ovary syndrome is an escalating endocrinal and reproductive
disorder among women of reproductive age and is considered the foremost health burden …

Objective: Polycystic ovary syndrome (PCOS) is a disorder of hyperandrogenemia and
chronic anovulation, which affects 5-10% of all women. It has been reported that women with …

Background The aim of this study was to examine the role of C-peptide as a biological
marker of cardiometabolic risk in polycystic ovary syndrome (PCOS). Methods This case …

Abstract Background: Polycystic Ovarian Sydrome (PCOS) is an intense problem which
manifiests later as infertility, obesity, insulin resistance, dyslipidemia, endothelial dysfunction …